Cargando…
A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis
FS102 is a HER2-specific Fcab (Fc fragment with antigen binding), which binds HER2 with high affinity and recognizes an epitope that does not overlap with those of trastuzumab or pertuzumab. In tumor cells that express high levels of HER2, FS102 caused profound HER2 internalization and degradation l...
Autores principales: | Leung, Kin-Mei, Batey, Sarah, Rowlands, Robert, Isaac, Samine J, Jones, Phil, Drewett, Victoria, Carvalho, Joana, Gaspar, Miguel, Weller, Sarah, Medcalf, Melanie, Wydro, Mateusz M, Pegram, Robert, Mudde, Geert C, Bauer, Anton, Moulder, Kevin, Woisetschläger, Max, Tuna, Mihriban, Haurum, John S, Sun, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817942/ https://www.ncbi.nlm.nih.gov/pubmed/26234505 http://dx.doi.org/10.1038/mt.2015.127 |
Ejemplares similares
-
Role of Fcγ receptors in HER2-targeted breast cancer therapy
por: Musolino, Antonino, et al.
Publicado: (2022) -
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
por: Rau, Alexander, et al.
Publicado: (2021) -
Molecular Dynamics Simulation of the Crystallizable Fragment of IgG1—Insights for the Design of Fcabs
por: Lai, Balder, et al.
Publicado: (2014) -
Financial Capability and Asset Building (FCAB) for Persons with Disabilities in Ghana: the Role of Social Workers
por: Naami, Augustina, et al.
Publicado: (2022) -
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
por: Pegram, Mark, et al.
Publicado: (2023)